Position in TRLV
as of Jun 30, 2026
· filed Sep 9, 2026
Position Value
$99,302
New position
Shares Held
10,102
first reported quarter
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#78
of 125 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Integrated Wealth Concepts LLC holds $9,209,617 across 15 Drug Manufacturers - Specialty & Generic names. TRLV ranks #14 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
18,709 | $2,075,576 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
8,041 | $1,355,230 | |
| 3 | VTRS |
Viatris Inc
|
83,273 | $1,322,375 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
2,055 | $1,113,460 | |
| 5 | PCRX |
Pacira BioSciences, Inc.
|
43,764 | $1,110,292 | |
| 6 | ZTS |
Zoetis Inc.
|
6,357 | $456,814 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
11,717 | $396,971 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
17,872 | $286,488 |
All Filings in TRLV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $99,302 | 10,102 | Shares | Sole | 2026-09-09 | |
| No filing history on record for this holder in this stock. | ||||||